Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (4 ops.)
Latest filing published 25 May 2022 for 10x Genomics, Inc., €13k. Read the official filing
Filing timeline
BuySaleBradford Crutchfield
Insider track record
Disclosed buys
1
Disclosed sells
4
T+90 hit rate
0%
T+90 mean return
-27.6%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Bradford Crutchfield: trading record in brief
Bradford Crutchfield (senior executive) discloses dealings in 10x Genomics, Inc. to SEC (Form 4). We count 17 filings; the first trade dates from 19 March 2021 and the latest from 23 May 2022.
Market trades split into 1 purchase (€6,163) and 4 sales (€107k). Netting one side against the other leaves €101k of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 1 share grant and 11 option exercises. In 2022 alone, the filings show 1 purchase and 2 sales.
On 25 May 2022 came the latest disclosure, an open-market sale for €13k in 10x Genomics, Inc. The last purchase on record was published on 17 May 2022, which is 1,615 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Bradford Crutchfield
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
286 shares@ US$48.76420.0006% mcap2.4% of flowClass A Common StockSEC:0001567619-22-011711:0
158 shares@ US$40.48550.0003% mcap1.1% of flowClass A Common StockSEC:0001567619-22-011119:0
Canonical exit: 11 Aug 2022 (T+90)
288 shares@ US$78.59930.0010% mcap3.7% of flowClass A Common StockSEC:0001567619-22-005519:0
17,000 shares@ US$1.160.0008% mcap3.3% of flowClass A Common StockSEC:0001567619-22-004884:0
17,000 shares@ US$1.166.0% of flowClass A Common StockSEC:0001567619-22-001197:0
4,688 shares@ US$1.201.7% of flowClass A Common StockSEC:0001567619-21-022503:0
17,000 shares@ US$1.166.1% of flowClass A Common StockSEC:0001567619-21-022118:0
281 shares@ US$148.381112.9% of flowClass A Common StockSEC:0001567619-21-021188:0
17,000 shares@ US$1.166.0% of flowClass A Common StockSEC:0001567619-21-020599:0
17,000 shares@ US$1.165.9% of flowClass A Common StockSEC:0001567619-21-018312:0
17,000 shares@ US$1.165.8% of flowClass A Common StockSEC:0001209191-21-056229:0
270 shares@ US$161.847512.9% of flowClass A Common StockSEC:0001209191-21-053390:0
17,000 shares@ US$1.165.8% of flowClass A Common StockSEC:0001209191-21-051618:0
17,000 shares@ US$1.165.8% of flowClass A Common StockSEC:0001209191-21-046677:0
17,000 shares@ US$1.165.7% of flowClass A Common StockSEC:0001209191-21-041034:0
8,935 shares0Class A Common StockSEC:0001209191-21-036100:0
17,000 shares@ US$1.165.7% of flowClass A Common StockSEC:0001209191-21-032476:0
17 of 17 declarations
